Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 6Ovarian Neoplasms 5Small Cell Lung Carcinoma 4Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Breast Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Unspecified Childhood Solid Tumor, Protocol Specific 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sexual Dysfunction, Physiological 1Sarcopenia 1Recurrence 1Pancreatic Neoplasms 1PROMs 1Ototoxicity 1Neurotoxicity Syndromes 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Hearing Loss 1Fatigue 1Fallopian Tube Neoplasms 1Eunuchism 1Esophageal Neoplasms 1Erectile Dysfunction 1Chemotherapy-induced Peripheral Neuropathy 1Central Nervous System Neoplasms 1

Interventions

Vincristine 1Surveys and Questionnaires 1Radiotherapy 1Radiosurgery 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Genetic Association Studies 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Ototoxicity × Carboplatin × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡